183 results
Page 5 of 10
6-K
EX-99.1
2n9z1qre
20 Oct 20
As Representatives of the several Underwriters
4:43pm
SUPPL
tjd6ww31e1obwnsh
20 Oct 20
Supplemental materials (foreign)
12:00am
SUPPL
ztpmk7wqun94b
19 Oct 20
Supplemental materials (foreign)
5:12pm
6-K
EX-99.1
j6pv1ijk 8jzt
8 Sep 20
BELLUS Health Announces Design for its Phase 2b Trial with BLU-5937 in Refractory Chronic Cough
7:00am
6-K
EX-99.2
2ecop4o p4j
13 Aug 20
Condensed Consolidated Interim Financial Statements of
4:01pm
6-K
EX-99.1
fifwm
13 Aug 20
BELLUS Health Reports Second Quarter 2020 Financial Results and Business Highlights
7:00am
6-K
EX-99.1
7vnc5idhoxode0 r2c
6 Jul 20
BELLUS Health Announces Topline Results from its Phase 2 RELIEF Trial of BLU-5937 for the Treatment of Refractory Chronic Cough
7:00am
6-K
EX-99.2
4b7h2vn063t8jedh
14 May 20
Condensed Consolidated Interim Financial Statements of
5:12pm
6-K
EX-99.1
4h7cdxpn 8xf6ia3
14 May 20
BELLUS Health Reports First Quarter 2020 Financial Results and Business Highlights, and Provides Updates on BLU-5937
5:00pm
6-K
EX-99.1
y4hb0 vgb14awl4v771
13 May 20
BELLUS Health Convenes Virtual KOL Meeting to Discuss the State of Chronic Cough Treatment and the BLU-5937 Program
7:00am
6-K
EX-99.1
nv0vyi30 2r
7 Apr 20
Bellus HEALTH 2019 ANNUAL REPORT
9:59am
6-K
EX-99.1
4gn ecsh82u0hjw
23 Mar 20
Current report (foreign)
8:11am
SUPPL
iytgu6e w2djfj16dr
23 Mar 20
Supplemental materials (foreign)
7:06am
40-F
EX-99.3
s7tzm sz8
27 Feb 20
Annual report (Canada)
5:13pm
40-F
EX-99.1
l9dpyz
27 Feb 20
Annual report (Canada)
5:13pm
F-10/A
wwsue
17 Jan 20
Registration of securities (Canada) (amended)
4:21pm
F-10
4sgv wj4ryj3xaykoh
20 Dec 19
Registration of securities (Canada)
4:03pm
F-10
EX-4.1
cpt12qt k2i
20 Dec 19
Registration of securities (Canada)
4:03pm
F-10
EX-4.2
x0nsy9spi m4
20 Dec 19
Registration of securities (Canada)
4:03pm
F-10
EX-4.3
ybnyrl3y 6m07ohtvkc
20 Dec 19
Registration of securities (Canada)
4:03pm